Literatur
Kristensen SD, Knuuti J, Saraste A et al (2014) 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 35(35):2383–2431
Bønaa KH, Mannsverk J, Wiseth R et al (2016) Drug-eluting or bare-metal Stents for coronary artery disease. N Engl J Med 375(13):1242–1252
Mehran R, Baber U, Steg PG et al (2013) Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 382(9906):1714–1722. doi:10.1016/s0140-6736(13)61720-1
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
H. Eggebrecht gibt an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Eggebrecht, H. Operation innerhalb des ersten Jahres nach Drug-eluting-Stentimplantation – Risikoreich?. Kardiologe 11, 155–156 (2017). https://doi.org/10.1007/s12181-017-0132-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12181-017-0132-6